Pharma's Almanac

195 Articles Available

1 9

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

PAO-07-23-CL-02

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

PAO-05-23-CL-03

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

PR-M03-23-03

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

PAO-11-022-CL-15

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

PAO-11-22-PATV-01

Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

PAO-11-022-CL-10

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

PAO-11-022-CL-05

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

PAO-09-022-CL-07

CRO

Crafting a Successful Partnership with a Contract Research Organization

PAO-06-022-CL-05

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

PAO-02-022-CL-14

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

PR-M03-22-05

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

PAO-02-022-CL-03

Business Leadership

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

PR-M03-22-04

Investment

Focusing on the Potential of Midsized Pharma Service Organizations

PAO-03-22-R250-03

CRO

Accelerating Large Molecule Drug Development

PAO-02-22-R250-20

Private Equity

Supporting Growth for Middle-Market Companies

PAO-02-22-R250-22

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

PAO-02-22-R250-10

CRO

Expanding a Full-Service CRO Offering into the United States

PAO-01-22-R250-01

M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

PR-M01-22-09

Clinical Trials Logistics

Listening to Clients and Expanding Across the Clinical Supply Chain

PAO-10-21-CL-19

Decentralized Clinical Trials

A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research

PAO-10-21-CL-04

Clinical Supply

Integrating a Personal Approach to Clinical Supply Services

PAO-09-21-CL-08

Early Development Studies

Complex Early Development Studies — Managing FIH to Phase Ib

PAO-08-21-CL-04

M&A

Thermo Fisher Scientific Acquires PPD and Leverages Clinical

PAO-06-21-MA-01

1 9

CRO

195 Articles Available

Can't find what you're looking for? Try our advanced search.

Decentralized Clinical Trials

Innovating DCTs Through Application and Cross-Functional Delivery

Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Artificial Intelligence in Antibody Design

Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

Asia-Pacific DCTs

Interest in Decentralized Trials Rising in Asia-Pacific

Decentralized Clinical Trial Design

Reducing the Challenges Sites Face when Implementing Decentralized Trials

European DCTs

Exploring Challenges and Considerations for Operationalizing DCTs in the European Union

CRO

Crafting a Successful Partnership with a Contract Research Organization

Gene Therapy Analytics

Overcoming Analytical Challenges for Gene Therapies

M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

Rare Disease Clinical Trials

Rare Disease Patients Benefit from Clinical Trial Flexibility

Business Leadership

Former Surgeon General Jerome Adams Announced as Chairman of the Board of Total Diversity Clinical Trial Management

Investment

Focusing on the Potential of Midsized Pharma Service Organizations

CRO

Accelerating Large Molecule Drug Development

Private Equity

Supporting Growth for Middle-Market Companies

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

CRO

Expanding a Full-Service CRO Offering into the United States

M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

Clinical Trials Logistics

Listening to Clients and Expanding Across the Clinical Supply Chain

Decentralized Clinical Trials

A Breath of Fresh Air: How Decentralized Trial Options are Changing Respiratory Research

Clinical Supply

Integrating a Personal Approach to Clinical Supply Services

Early Development Studies

Complex Early Development Studies — Managing FIH to Phase Ib

M&A

Thermo Fisher Scientific Acquires PPD and Leverages Clinical